These 4 Biotech Penny Stocks Are Buys, According to Analysts
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
COVID-related Names
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.